1. Home
  2. DIAX vs NUS Comparison

DIAX vs NUS Comparison

Compare DIAX & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DIAX
  • NUS
  • Stock Information
  • Founded
  • DIAX 2005
  • NUS 1984
  • Country
  • DIAX United States
  • NUS United States
  • Employees
  • DIAX N/A
  • NUS N/A
  • Industry
  • DIAX Finance Companies
  • NUS Other Pharmaceuticals
  • Sector
  • DIAX Finance
  • NUS Health Care
  • Exchange
  • DIAX Nasdaq
  • NUS Nasdaq
  • Market Cap
  • DIAX 523.0M
  • NUS 440.8M
  • IPO Year
  • DIAX N/A
  • NUS 1996
  • Fundamental
  • Price
  • DIAX $14.33
  • NUS $8.96
  • Analyst Decision
  • DIAX
  • NUS Hold
  • Analyst Count
  • DIAX 0
  • NUS 2
  • Target Price
  • DIAX N/A
  • NUS $6.88
  • AVG Volume (30 Days)
  • DIAX 96.6K
  • NUS 484.8K
  • Earning Date
  • DIAX 01-01-0001
  • NUS 08-07-2025
  • Dividend Yield
  • DIAX 7.93%
  • NUS 2.67%
  • EPS Growth
  • DIAX N/A
  • NUS N/A
  • EPS
  • DIAX N/A
  • NUS N/A
  • Revenue
  • DIAX N/A
  • NUS $1,679,268,000.00
  • Revenue This Year
  • DIAX N/A
  • NUS N/A
  • Revenue Next Year
  • DIAX N/A
  • NUS N/A
  • P/E Ratio
  • DIAX N/A
  • NUS N/A
  • Revenue Growth
  • DIAX N/A
  • NUS N/A
  • 52 Week Low
  • DIAX $12.80
  • NUS $5.32
  • 52 Week High
  • DIAX $15.12
  • NUS $11.64
  • Technical
  • Relative Strength Index (RSI)
  • DIAX 54.01
  • NUS 54.66
  • Support Level
  • DIAX $14.17
  • NUS $8.16
  • Resistance Level
  • DIAX $14.38
  • NUS $8.64
  • Average True Range (ATR)
  • DIAX 0.11
  • NUS 0.31
  • MACD
  • DIAX -0.01
  • NUS -0.08
  • Stochastic Oscillator
  • DIAX 32.50
  • NUS 35.66

About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest

Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

Share on Social Networks: